An investigation of dapsone compliance using an isoniazid-marked formulation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002214:Capsules; D003404:Creatinine / Q000652:urine; D003622:Dapsone / Q000008:administration & dosage* / Q000652:urine; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012646:Self Administration / Q000379:methods; D013607:Tablets
D002214:Capsules; D004338:Drug Combinations; D013607:Tablets; D003622:Dapsone; D003404:Creatinine; D007538:Isoniazid